Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Sage Therapeutics Inc
About SAGE
Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed two FDA-approved treatments indicated for postpartum depression (PPD) and is advancing a portfolio of internally discovered novel chemical entities with the potential to become differentiated treatments designed to improve brain health by primarily targeting two critical central nervous system, receptor systems, GABA and NMDA. Its product ZURZUVAE is for the treatment of PPD in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors, and is the first oral, once-daily, 14-day treatment specifically indicated for adults with PPD. It is also evaluating potential indications for SAGE-324, a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing, including seizures in developmental and epileptic encephalopathies. Its other areas of focus are SAGE-319, SAGE-039, and SAGE-817.
Find out what a historical investment in Sage Therapeutics Inc would be worth today using our SAGE stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy SAGE shares in Australia?
Buying SAGE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Sage Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SAGE
What is the ticker symbol of Sage Therapeutics Inc?
The ticker symbol for Sage Therapeutics Inc is SAGE.
How much is one share of SAGE?
One share of SAGE is valued at $8.70 as of 20 May 2026.
What is the market capitalisation of Sage Therapeutics Inc SAGE?
As of 20 May 2026 Sage Therapeutics Inc has a market cap of -.
What is the 52-week high for Sage Therapeutics Inc stock?
The Sage Therapeutics Inc 52-week high stock price is $NaN.
What is the 52-week low for Sage Therapeutics Inc stock?
The Sage Therapeutics Inc 52-week low stock price is $NaN.
Can I buy SAGE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SAGE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SAGE on Stake
- Buy SAGE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SAGE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SAGE related stocks